Snail transcription factor negatively regulates maspin tumor suppressor in human prostate cancer cells

BackgroundMaspin, a putative tumor suppressor that is down-regulated in breast and prostate cancer, has been associated with decreased cell motility. Snail transcription factor is a zinc finger protein that is increased in breast cancer and is associated with increased tumor motility and invasion by induction of epithelial-mesenchymal transition (EMT). We investigated the molecular mechanisms by which Snail increases tumor motility and invasion utilizing prostate cancer cells.MethodsExpression levels were analyzed by RT-PCR and western blot analyses. Cell motility and invasion assays were performed, while Snail regulation and binding to maspin promoter was analyzed by luciferase reporter and chromatin immunoprecipitation (ChIP) assays.ResultsSnail protein expression was higher in different prostate cancer cells lines as compared to normal prostate epithelial cells, which correlated inversely with maspin expression. Snail overexpression in 22Rv1 prostate cancer cells inhibited maspin expression and led to increased migration and invasion. Knockdown of Snail in DU145 and C4-2 cancer cells resulted in up-regulation of maspin expression, concomitant with decreased migration. Transfection of Snail into 22Rv1 or LNCaP cells inhibited maspin promoter activity, while stable knockdown of Snail in C4-2 cells increased promoter activity. ChIP analysis showed that Snail is recruited to the maspin promoter in 22Rv1 cells.ConclusionsOverall, this is the first report showing that Snail can negatively regulate maspin expression by directly repressing maspin promoter activity, leading to increased cell migration and invasion. Therefore, therapeutic targeting of Snail may be useful to re-induce expression of maspin tumor suppressor and prevent prostate cancer tumor progression.

[1]  Leila Mohammadi,et al.  BMC Cancer , 2001 .

[2]  P. Lizardi,et al.  Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor , 2008, Molecular Cancer Therapeutics.

[3]  M. Hendrix,et al.  Aberrant methylation of the maspin promoter is an early event in human breast cancer. , 2004, Neoplasia.

[4]  Z. Culig,et al.  Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cells , 2010, Endocrine-related cancer.

[5]  M. Hung,et al.  Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition , 2004, Nature Cell Biology.

[6]  E. Hay.  An overview of epithelio-mesenchymal transformation. , 1995, Acta anatomica.

[7]  M. Hendrix,et al.  Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. , 1994, Science.

[8]  M. Hendrix,et al.  Epigenetic silencing of maspin gene expression in human breast cancers , 2000, International journal of cancer.

[9]  T. Ørntoft,et al.  Snail1 is over‐expressed in prostate cancer , 2009, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[10]  Ellen M. Langer,et al.  The Ajuba LIM domain protein is a corepressor for SNAG domain mediated repression and participates in nucleocytoplasmic Shuttling. , 2007, Cancer research.

[11]  A. G. Herreros,et al.  The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells , 2000, Nature Cell Biology.

[12]  M. Hendrix,et al.  Maspin Regulates Different Signaling Pathways for Motility and Adhesion in Aggressive Breast Cancer Cells , 2003, Cancer biology & therapy.

[13]  Y. Oshika,et al.  P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo. , 1996, British Journal of Cancer.

[14]  Wei Zhang,et al.  Maspin expression profile in human prostate cancer (CaP) and in vitro induction of Maspin expression by androgen ablation. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  Shoichiro Tsukita,et al.  Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail , 2003, Journal of Cell Science.

[16]  Z. Khalkhali‐Ellis.  Maspin: The New Frontier , 2006, Clinical Cancer Research.

[17]  F. Domann,et al.  Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression , 2003, Oncogene.

[18]  R. Sager,et al.  Expression of maspin in prostate cells is regulated by a positive ets element and a negative hormonal responsive element site recognized by androgen receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Robert D Cardiff,et al.  The transcriptional repressor Snail promotes mammary tumor recurrence. , 2005, Cancer cell.

[20]  M. Karin,et al.  Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin , 2009, Nature.

[21]  M. Hendrix,et al.  Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells , 2005, Cancer biology & therapy.

[22]  Ellen M Langer,et al.  The LIM Protein AJUBA Recruits Protein Arginine Methyltransferase 5 To Mediate SNAIL-Dependent Transcriptional Repression , 2008, Molecular and Cellular Biology.

[23]  V. Odero-Marah,et al.  Snail negatively regulates cell adhesion to extracellular matrix and integrin expression via the MAPK pathway in prostate cancer cells , 2011, Cell adhesion & migration.

[24]  N. Kyprianou,et al.  Role of androgens and the androgen receptor in epithelial‐mesenchymal transition and invasion of prostate cancer cells , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  J. Thiery.  Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[26]  W. Kolch,et al.  Snail is a repressor of RKIP transcription in metastatic prostate cancer cells , 2008, Oncogene.

[27]  R. Sager,et al.  The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin. , 2000, Cancer research.

[28]  J. Licht,et al.  ATF-2 controls transcription of Maspin and GADD45α genes independently from p53 to suppress mammary tumors , 2008, Oncogene.

[29]  Francisco Portillo,et al.  The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression , 2000, Nature Cell Biology.

[30]  B. Boyer,et al.  Induction and regulation of epithelial-mesenchymal transitions. , 2000, Biochemical pharmacology.

[31]  L. Chung,et al.  Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. , 1994, Cancer research.

[32]  R. Momparler,et al.  Synergistic antineoplastic action of DNA methylation inhibitor 5‐AZA‐2′‐deoxycytidine and histone deacetylase inhibitor depsipeptide on human breast carcinoma cells , 2003, International journal of cancer.

[33]  H. Kang,et al.  Blocking of p53-Snail binding, promoted by oncogenic K-Ras, recovers p53 expression and function. , 2009, Neoplasia.

[34]  David A. Cheresh,et al.  Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin , 2007, Nature.

[35]  L. Chung,et al.  Snail transcription factor regulates neuroendocrine differentiation in LNCaP prostate cancer cells , 2010, The Prostate.

[36]  S. Lau,et al.  5-Aza-2′-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation , 2007, Oncogene.

[37]  F. Marshall,et al.  Receptor activator of NF-κB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells , 2008, Cell Research.

[38]  Kazuhiro Yoshida,et al.  Loss of maspin expression is associated with development and progression of gastric carcinoma with p53 abnormality. , 2004, Oncology reports.

[39]  E. Appella,et al.  p53 Regulates the Expression of the Tumor Suppressor Gene Maspin* , 2000, The Journal of Biological Chemistry.